Compare Ecolab Inc. (ECL) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs Zoetis Inc — how do they compare? Ecolab Inc. trades at $280.35 (market cap $79.79B), while Zoetis Inc trades at $72.39 (market cap $31.14B). The key difference: Ecolab Inc. is far larger — about 2.6× Zoetis Inc's market cap, and Zoetis Inc pays the higher dividend (2.81%). Which is the better fit depends on your goals.
| ECL | ZTS | |
|---|---|---|
Market Cap | $79.79B | $31.14B |
Sector | Consumer Cyclical | Health |
52-Week High | $308.35 | $156.76 |
52-Week Low | $245.73 | $71.91 |
Enterprise Value | $88.57B | $38.70B |
Dividend Yield | 1.03% | 2.81% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ECL trades at $284.4, down slightly (-0.27%) on the day, with a bullish technical signal and strong analyst support (78% buy ratings). The company reported solid Q2 2026 earnings of $2.09 per share, beating estimates, and raised full-year guidance. Revenue growth is steady, with 2025 revenue at $16.08B, and profitability remains robust with a net income margin of 12.57%. Recent news highlights institutional activity and the completion of the $4.75B CoolIT acquisition, strengthening its high-tech portfolio.
The outlook is positive, driven by earnings momentum, strategic acquisitions, and a consensus price target of $327.90 implying ~15% upside. Key risks include execution of integration for recent acquisitions, input cost pressures, and broader market volatility. The stock presents a compelling opportunity for growth investors seeking exposure to a stable, dividend-paying company with digital and high-tech expansion drivers.
Zoetis (ZTS) trades at $74.86, up 3.03% today but facing bearish technical signals with 16 sell indicators. The company reported mixed Q2 2026 results, beating EPS estimates but missing revenue expectations, while cutting full-year guidance due to softer pet healthcare demand. Strong fundamentals include a 27.69% net margin and 64.91% ROE, though valuation metrics show a P/E of 12.29 and P/S of 3.41.
The stock presents a value opportunity with analyst consensus target of $94.90 (27% upside), but faces near-term headwinds from competitive pressures and class action lawsuits. Investors should weigh strong profitability against slowing growth in companion animal segments and technical bearishness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
